display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2)
metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2)
sotorasib sotorasib NICE ITC Flatiron CodeBreaK 100 CodeBreaK 200 sotorasib NICE ITC 1

Study type: